Evaluation of the Reproducibility of the Naranjo Adverse Drug Reaction Probability Scale Score in Published Case Reports

被引:26
|
作者
Liang, Ruby [1 ,2 ]
Borgundvaag, Bjug [3 ,4 ]
McIntyre, Mark [1 ]
Thwaites, Crystal [1 ]
Ragan, Kelsey [5 ]
Wyllie, Andrew [1 ]
机构
[1] Mt Sinai Hosp, Dept Pharm, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[3] Mt Sinai Hosp, Schwartz Reisman Emergency Med Inst, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Fac Med, Toronto, ON, Canada
来源
PHARMACOTHERAPY | 2014年 / 34卷 / 11期
关键词
Naranjo Adverse Drug Reaction Probability Scale; reproducibility; case reports; causality; CAUSALITY ASSESSMENT; EVENT REPORTS; PATIENT; THERAPY;
D O I
10.1002/phar.1496
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
STUDY OBJECTIVE To assess the reproducibility of Naranjo Adverse Drug Reaction Probability Scale (APS) scores in published case reports. DESIGN Reliability analysis. MEASUREMENTS AND MAIN RESULTS Randomly selected case reports using the APS were identified from the Web of Science database. The APS scores were blinded from the case reports, and scores were then independently calculated by four raters, using the APS. The percentage of exact agreement between raters' and the published APS scores was calculated for all case reports. Categorical scores were compared by using a weighted kappa statistic. For numerical scores, descriptive statistics were computed by using raw and absolute difference scores. Twenty-four case reports were independently scored by four raters. Exact agreement between all raters' scores and the published APS scores was found in five (21%) of the 24 reports. Agreement between individual rater's scores and the published categorical score ranged from 42% to 79%. Weighted kappa ranged from 0.12 to 0.61, corresponding to strengths of agreement between poor and good. Difference in scoring by raters resulted in 18% and 27% of case reports being reclassified into higher and lower than reported APS categories, respectively. CONCLUSION Exact agreement between raters' scores and the published APS score was infrequent. We recommend that authors of case reports include all pertinent details of the case and that journals ensure the robustness of the causality assessment during peer review.
引用
收藏
页码:1159 / 1166
页数:8
相关论文
共 50 条
  • [1] Misuse of the Naranjo Adverse Drug Reaction probability scale in toxicology
    Seger, D.
    Barker, K.
    McNaughton, C.
    [J]. CLINICAL TOXICOLOGY, 2013, 51 (06) : 461 - 466
  • [2] Assessing the quality of published adverse drug reaction case reports using the Naranjo criteria.
    Felton, Maria
    Rihtarchik, Lindsey
    Resetar, Erin
    Wang, Nan
    Kane-Gill, Sandra
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E263 - E263
  • [3] Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale
    Kose, Samet
    Akin, Ercan
    Cetin, Mesut
    [J]. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 27 (02) : 210 - 211
  • [4] Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury
    Garcia-Cortes, M.
    Lucena, M. I.
    Pachkoria, K.
    Borraz, Y.
    Hidalgo, R.
    Andrade, R. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (09) : 780 - 789
  • [5] Establishing causality in pediatric adverse drug reactions: Use of the Naranjo probability scale
    Avner M.
    Finkelstein Y.
    Hackam D.
    Koren G.
    [J]. Pediatric Drugs, 2007, 9 (4) : 267 - 270
  • [6] A Retrospective Evaluation of Cutaneous Adverse Drug Reactions (CADRs) Due to Antibiotics Using Naranjo Adverse Drug Reactions (ADRs) Probability Scale
    Shalayel, Mohammed Helmy Faris
    Ayed, Ietimad Abdelsalam Mohamed
    Huneif, Mohammed Ayed
    Kordofani, Yousif Mohammed
    [J]. JOURNAL OF YOUNG PHARMACISTS, 2018, 10 (01) : 113 - 116
  • [7] Ciprofloxacin induced toxic epidermal necrolysis with cholestatic hepatitis: A case report with literature review and revisit to the Naranjo adverse drug reaction probability scale
    Dhakal, Bishal
    Dawadi, Sagun
    Khadka, Laxman
    Bohara, Sujan
    Neupane, Shashank
    Magar, Priajan Ale
    Pathak, Bishnu Deep
    Regmi, Binit Upadhaya
    [J]. CLINICAL CASE REPORTS, 2022, 10 (12):
  • [8] Modified Naranjo Scale Assessment of Adverse Reaction Causality
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 299 - 300
  • [10] Quality of published case reports on adverse drug reactions in children
    Impicciatore, Piero
    Iato, Valeria
    Sevoz, Vincent
    Mucci, Massimiliano
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2012, 97 (09) : 853 - 853